Thrive Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $283K | Sell |
4,047
-88
| -2% | -$6.15K | 0.05% | 181 |
|
|
2025
Q1 | $304K | Buy |
4,135
+301
| +8% | +$22.1K | 0.06% | 161 |
|
|
2024
Q4 | $251K | Sell |
3,834
-149
| -4% | -$9.76K | 0.05% | 169 |
|
|
2024
Q3 | $310K | Buy |
3,983
+22
| +0.6% | +$1.71K | 0.06% | 165 |
|
|
2024
Q2 | $309K | Sell |
3,961
-59
| -1% | -$4.6K | 0.06% | 157 |
|
|
2024
Q1 | $272K | Buy |
4,020
+192
| +5% | +$13K | 0.06% | 169 |
|
|
2023
Q4 | $258K | Sell |
3,828
-38
| -1% | -$2.56K | 0.06% | 157 |
|
|
2023
Q3 | $262K | Buy |
3,866
+49
| +1% | +$3.32K | 0.07% | 138 |
|
|
2023
Q2 | $273K | Buy |
+3,817
| New | +$273K | 0.07% | 142 |
|